Tyto Care
Tyto Care sells remote physical exam devices and software that health systems, health plans and other care organizations run with their own clinicians. The Home Smart Clinic lets patients or caregivers capture heart and lung sounds, ear, throat and skin images and temperature at home with a handheld device, and the Pro Smart Clinic lets staff at a clinic, school or senior care site run the exam for a remote clinician. Tyto Insights adds FDA cleared AI that flags suspected wheezes, crackles and rhonchi in stethoscope recordings, with a predetermined change control plan for the wheeze module, and a De Novo authorized module that detects eardrum bulging in otoscope video. Clinicians review each result beside the recording, and a recording the software cannot analyze is flagged as such. Smart Checkup guides patients through an AI symptom check in before connecting them to a clinician, and exam data can flow into Epic.
Tyto reports more than 240 healthcare organizations, 8 million virtual exams and 1.6 million patients, with Sanford Health, Corewell Health, Advocate Aurora Health, MUSC and Cincinnati Children's among its customers. A Journal of Health Economics study of more than 28,000 users over three years found 7% lower total cost of care and 24% fewer ER visits. Deployments are quoted per program, and the Tyto Health Hub for high risk patients is in development and not for sale.
Capability Axes
An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read
Remote exam hardware and video care carry the platform, and Tyto Insights is the model driven module on top. The handheld device, guided capture, apps and clinician workspace have sold for years without analysis, and more than 8 million exams run on them.
The Insights modules exist only as model output: suspected wheeze, crackles and rhonchi in stethoscope recordings and eardrum bulging in otoscope video, each cleared or authorized separately, with Smart Checkup's AI symptom check in alongside. Remove the models and the exam platform still sells, while the detection modules do not exist.
A clinician triggers lung sound analysis during a video exam and reviews the result in the provider app beside the recording and the rest of the exam, and the software either flags a suspected abnormal sound or says the recording could not be analyzed, so the clinician can repeat it. The intended use leaves the overall assessment to the clinician, and a care team chooses which features its users see. The analysis returns a finding without anyone approving its generation and issues no treatment decision. No confidence threshold or path for reporting a wrong flag is described.
FDA filings describe the regulated modules. The wheeze module takes recordings from the compatible Tyto Stethoscope and returns suspected wheeze or a cannot analyze result, leaving other sounds to their own modules, under a predetermined change control plan that governs how it may be updated. The eardrum module analyzes otoscope video and was trained on 3,102 otoscopic recordings from Tyto's real world data. Architecture and change controls are set out only for these regulated modules, and nothing comparable covers Smart Checkup or the rest of the platform.
Tyto builds the Insights modules itself for its own exam devices, a short chain: the telehealth server passes recordings from the point of care app to the wheeze module's web service and the result returns to the clinician app, and the cleared modules cannot be swapped without the regulatory change controls that govern them. Providers can add outside clinical systems and connected devices. The hosting and support providers that process raw recordings for analysis are not named.
A matched study in the Journal of Health Economics, by Stanford economists, followed more than 28,000 users over three years and found device assisted telemedicine raised primary care use by about 12%, cut total cost of care by 7% and lowered ER use by 24%. The crackles module reached an area under the curve of 0.97 in its FDA submission, with sensitivity of 0.72 in the reported comparison, on records from its intended population.
Tyto also reports a Medicaid pediatric program with 60% fewer ED visits against 7.9% for video alone and 98% of visits resolved without in person follow up, from company data. The proposed Health Hub has no results.
Messages, voice, video and exam content are encrypted, measurements travel over protected connections, and users and providers set who can see the medical record. The analysis flags a recording it cannot analyze rather than guessing, and the clinician can always open the underlying exam data. Tyto trains its models on exam recordings from its own real world database, 3,102 otoscopic recordings for the eardrum module alone, per the FDA filing. The general terms set no limit on using a customer's identifiable exam recordings for training and give no retention period, so the assurances stop at encryption and access.
Exam data goes from the app to a hosted platform for patients and their clinicians, encrypted in transit and behind record access controls, and Tyto shows a HIPAA compliant mark. Its privacy terms undertake to protect personal information where Tyto acts as a business associate and defer to any signed agreement with the provider.
No business associate agreement for the exam software, devices or analysis services is published, and its coverage is settled in each provider engagement, which can differ with the role the clinic or plan takes.
SOC 2 Type 2 and ISO 27001 marks appear on Tyto's homepage beside HIPAA and GDPR, and device quality and clinical clearances are reported separately. Exam data is encrypted in transit and at rest in hosting, and authentication and permissions limit who sees the record. No report, certificate number, date or scope is published and there is no trust portal, so whether the audits cover the exam apps, the analysis services and outside providers is settled in each provider's security review.
FDA cleared wheeze detection under K252844 with a predetermined change control plan, for recordings from a compatible Tyto Stethoscope in adults and children aged two and older; crackles and rhonchi have separate clearances, K240555 and K243567; and FDA granted De Novo classification DEN250014 to eardrum bulging detection for patients aged six months and older. Each authorization covers a defined function, compatible hardware and intended use, and clinicians review results within the exam. The Tyto Health Hub is in development, not FDA cleared and not for sale.
A regulator reviewed change control plan governs how the cleared wheeze module may be updated and re evaluated, and each lung sound and eardrum module was evaluated against clinical comparison data for a defined intended population. Clinicians can check the source recording before relying on a result. No performance results broken out by age, sex, skin tone or recording conditions are published for any module, and no monitoring results are shared across the exam portfolio.
Clinicians assess each flag in context with the recording and the full exam, and a recording the software cannot analyze is labeled rather than scored. Tyto's service terms place clinical advice and its reliability with the treating professional, disclaim warranties about the service's operation and results and limit responsibility for outcomes. An inaccurate flag or a missed finding has no remedy of its own, and enterprise commitments sit in each provider contract.
Epic integration, listed on Epic's App Orchard, supports the telehealth workflow and moves exam information into the record after a visit. The wheeze module takes recordings over an API from the telehealth server and returns results to the clinician app, and the platform can work with connected devices and its own clinical interface. Other record integrations are arranged with each provider organization, and no public interface specification lists the systems and directions supported.
A handheld device and connected apps capture exams and deliver them to a hosted clinician workspace, and lung sound analysis runs on a web server linked to the telehealth app. Tyto's privacy terms allow processing in the United States, Canada, the European Union and Israel. No default location is committed for patient exam recordings or analysis, and no locally hosted option is offered in the standard program.
Health systems, plans, risk bearing groups, home health agencies, employers and life sciences companies contract for a program: Home Smart Clinic kits for patients and caregivers, Pro Smart Clinic for staff assisted exams in clinics, schools and senior care, and the platform and workflow around them. Wheeze detection is a premium option in the clinician software. Hardware, platform and module charges are set in each enterprise purchase, and no price is published for any device or program.
Settings are named and backed: homes, with more than 400,000 reached, plus clinics, schools and senior care sites through Pro Smart Clinic, across remote urgent, primary and specialty care and chronic care follow up. Each AI module states its population and hardware, from children aged two and older for wheeze detection to six months and older for eardrum bulging.
The Journal of Health Economics study, a Medicaid pediatric program and Sanford Health's rural deployment, which saved patients 1 to 3 hours of travel each way, support the home and primary care settings.
Alternatives to Tyto Care
Other products that do the same kind of work as Tyto Care, and what each one does.
hellocare.ai, operated by Solaborate Inc of Clearwater, Florida, is an inpatient virtual care platform combining software, hardware and AI, sold to hospitals, home care and primary care.
Biofourmis monitors patients at home and tries to detect deterioration before it becomes an admission.
Clinii sells care management software to physician groups, independent practices, health systems and organizations running chronic care programs.
DentalMonitoring analyzes smartphone images of teeth and orthodontic appliances between office visits, for orthodontists and dental practices in 50 countries.
PaceMate makes PaceMateLIVE, a cloud platform for remote cardiac monitoring that aggregates data from implanted cardiac devices across manufacturers, pairs it with electronic health record data, triages the resulting alerts and automates the billing documentation remote monitoring depends on.
Neurotrack describes itself as a cognitive care enablement platform: digital cognitive assessments, an adaptive layer it calls Smart Logic, and care planning support, sold to help providers assess, diagnose and care for people with mild cognitive impairment and dementia.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Contact for program quote
|
Health systems and plans purchase a configured platform and device deployment. The clinician software offers lung sound analysis as a premium module. Program scope varies by setting, device deployment and integration. | Tyto acts as a business associate where applicable. The provider contract governs the business associate agreement for the applicable data processing. | Setup and integration charges are agreed for each device rollout and the record systems being connected. | Vendor Published |
The organization agrees rates, device costs and applicable premium functions in its program contract.